Clincosm LogoSign in Get a demo

Intrahepatic Cholangiocarcinoma

Showing 26 - 50 of 87
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Intrahepatic Cholangiocarcinoma Trial in Shanghai (Toripalimab, Lenvatinib mesylate capsules, Placebo IV)

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • Shanghai, Shanghai, China
    Zhongshan Hospital affiliated to Fudan University
Aug 12, 2022

Solid Tumor, Adult, Intrahepatic Cholangiocarcinoma, Urothelial Carcinoma Trial in Taiwan, United States (KIN-3248)

Recruiting
  • Solid Tumor, Adult
  • +2 more
  • La Jolla, California
  • +4 more
Aug 9, 2022

/or PD-1 Inhibitors for Unresectable Intrahepatic

Completed
  • Intrahepatic Cholangiocarcinoma
  • hepatic arterial infusion chemotherapy (HAIC) of oxaliplatin, fluorouracil, and leucovorin (FOLFOX)
  • GuangZhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 7, 2022

Intrahepatic Cholangiocarcinoma Trial in GuangZhou (HAIC Combined with Tislelizumab and Apatinib)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • HAIC Combined with Tislelizumab and Apatinib
  • GuangZhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 4, 2022

Colorectal Cancer Metastatic to Liver, Intrahepatic Cholangiocarcinoma Trial in Philadelphia (Medtronic SynchroMed II

Recruiting
  • Colorectal Cancer Metastatic to Liver
  • Intrahepatic Cholangiocarcinoma
  • Medtronic SynchroMed II programmable pump connected to an Intera tapered catheter (Combined Infusion System)
  • Philadelphia, Pennsylvania
    Hospital of the University of Pennsylvania
Jul 14, 2022

Biliary Tract Cancer (CCA), Intrahepatic Cholangiocarcinoma, Hilar Cholangiocarcinoma Trial in Frankfurt am Main (Durvalumab,

Recruiting
  • Biliary Tract Cancer (CCA)
  • +4 more
  • Frankfurt am Main, Germany
    Krankenhaus Nordwest
Jun 23, 2022

Intrahepatic Cholangiocarcinoma Trial in Fairfax (Induction Chemotherapy Triplet Therapy, Concurrent Y-90 treatment,

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • Induction Chemotherapy Triplet Therapy
  • +2 more
  • Fairfax, Virginia
    Inova Schar Cancer Institute
Jun 14, 2022

Primary Liver Cancer, Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma Trial in China (Observation)

Recruiting
  • Primary Liver Cancer
  • +3 more
  • Observation
  • Beijing, Beijing, China
  • +4 more
Jun 14, 2022

Intrahepatic Cholangiocarcinoma Trial in Bad Saarow (Atezolizumab, Derazantinib)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • Bad Saarow, Germany
    HELIOS KLinikum Bad Saarow
Jun 2, 2022

Intrahepatic Cholangiocarcinoma Trial in Shanghai (Camrelizumab, US/CT-guided Percutaneous Cryoablation)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 1, 2022

Intrahepatic Cholangiocarcinoma Trial in Guangzhou (HAIC Combined with Tislelizumab and Apatinib)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • HAIC Combined with Tislelizumab and Apatinib
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
May 28, 2022

Early and Differential Diagnosis of Intrahepatic

Recruiting
  • Intrahepatic Cholangiocarcinoma
    • Jinan, Shandong, China
      Department of Gastroenterology,Qilu Hospital,Shandong University
    Apr 7, 2022

    Intrahepatic Cholangiocarcinoma Trial in Philadelphia (Perflutren Protein-Type A Microspheres, Contrast-Enhanced Ultrasound)

    Recruiting
    • Intrahepatic Cholangiocarcinoma
    • Perflutren Protein-Type A Microspheres
    • Contrast-Enhanced Ultrasound
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Apr 7, 2022

    Intrahepatic Cholangiocarcinoma Trial in Germany (Durvalumab, Tremelimumab)

    Recruiting
    • Intrahepatic Cholangiocarcinoma
    • Dresden, Germany
    • +7 more
    Apr 13, 2022

    Intrahepatic Cholangiocarcinoma Trial in Toronto (Deceased donor Liver Transplantation)

    Recruiting
    • Intrahepatic Cholangiocarcinoma
    • Deceased donor Liver Transplantation
    • Toronto, Ontario, Canada
      University Health Network
    Apr 8, 2022

    Intrahepatic Cholangiocarcinoma Trial in Worldwide (Cisplatin-gemcitabine, Radiation: SIRT + chemo (cisplatin-gemcitabine))

    Active, not recruiting
    • Intrahepatic Cholangiocarcinoma
    • Spokane, Washington
    • +22 more
    Apr 1, 2022

    Intrahepatic Cholangiocarcinoma Trial in Shanghai (GP+PD-1+Tight)

    Withdrawn
    • Intrahepatic Cholangiocarcinoma
    • Shanghai, Shanghai, China
      Zhongshan hospital, Fudan University
    Mar 22, 2022

    Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma Trial (VG161)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • Intrahepatic Cholangiocarcinoma
    • (no location specified)
    Mar 22, 2022

    Bile Duct Cancer, Intrahepatic Cholangiocarcinoma Trial in Durham, Columbus, Memphis (Melphalan/HDS, Cisplatin and Gemcitabine)

    Active, not recruiting
    • Bile Duct Cancer
    • Intrahepatic Cholangiocarcinoma
    • Melphalan/HDS
    • Cisplatin and Gemcitabine
    • Durham, North Carolina
    • +2 more
    Mar 23, 2022

    Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Stage IV Liver Cancer Trial in Seattle (Computed Tomography, Single

    Recruiting
    • Hepatocellular Carcinoma
    • +5 more
    • Computed Tomography
    • +2 more
    • Seattle, Washington
    • +1 more
    Feb 24, 2022

    Intrahepatic Cholangiocarcinoma, Combined Hepatocellular and Cholangiocarcinoma Trial in Worldwide (derazantinib)

    Recruiting
    • Intrahepatic Cholangiocarcinoma
    • Combined Hepatocellular and Cholangiocarcinoma
    • Phoenix, Arizona
    • +40 more
    Mar 7, 2022

    Intrahepatic Cholangiocarcinoma Trial in Tianjin (Sintilimab, IBI305, GEMOX)

    Recruiting
    • Intrahepatic Cholangiocarcinoma
    • Tianjin, Tianjin, China
      Tianjin Medical University Cancer Institute & Hospital
    Feb 22, 2022

    Intrahepatic Cholangiocarcinoma Trial (Transcatheter arterial chemoembolization, Multi-target Drug Therapy, Immunocheckpoint

    Not yet recruiting
    • Intrahepatic Cholangiocarcinoma
    • Transcatheter arterial chemoembolization
    • +3 more
    • (no location specified)
    Feb 17, 2022

    Treat Primary and Metastatic Liver Tumors

    Enrolling by invitation
    • Intrahepatic Cholangiocarcinoma
    • +3 more
      • Dallas, Texas
        Methodist Dallas Medical Center
      Feb 3, 2022

      Intrahepatic Cholangiocarcinoma Trial (DEB-TACE combined with Surufatinib and Camrelizumab)

      Not yet recruiting
      • Intrahepatic Cholangiocarcinoma
      • DEB-TACE combined with Surufatinib and Camrelizumab
      • (no location specified)
      Feb 9, 2022